Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation

被引：4

作者：

Lastrucci, Irene ^{[1
]}

Grandi, Vieri ^{[1
,2
]}

Gozzini, Antonella ^{[3
]}

Vannucchi, Margherita ^{[4
]}

Kovalchuk, Sofya ^{[3
]}

Santucci, Marco ^{[4
]}

Pimpinelli, Nicola ^{[1
]}

机构：

[1] Univ Florence, Sch Med, Sect Dermatol, Dept Hlth Sci, Florence, Italy

[2] GSTT NHS Fdn Trust, St Johns Inst Dermatol, London, England

[3] Univ Florence, Dept Expt & Clin Med, Sect Hematol, Sch Med, Florence, Italy

[4] Univ Florence, Dept Hlth Sci, Sch Med, Sect Pathol Anat, Florence, Italy

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 2021年 / 60卷 / 06期

关键词：

D O I：

10.1111/ijd.15393

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：778 / 780

页数：3

共 50 条

[41] Hepatosplenic gamma-delta T-cell lymphoma [J].

Ferreri, Andres J. M. ;

Govi, Silvia ;

Pileri, Stefano A. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (02) :283-292

[42] AzathioprineHepatosplenic gamma-delta T-cell lymphoma: case report [J].

Reactions Weekly, 2023, 1940 (1) :93-93

[43] Primary Cutaneous Gamma-Delta T-Cell Lymphoma Initially Diagnosed as Subcutaneous Panniculitis-like T-Cell Lymphoma with Dermatomyositis [J].

Hirata, Chika ;

Nakai, Kozo ;

Kurasawa, Yusuke ;

Maekawa, Naoki ;

Kuniyuki, Shuichi ;

Yamagami, Keiko ;

Ohsawa, Masahiko ;

Tsuruta, Daisuke .

DERMATOPATHOLOGY, 2022, 9 (02) :143-147

[44] Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: A systematic review [J].

Schlaak, M. ;

Theurich, S. ;

Pickenhain, J. ;

Skoetz, N. ;

Kurschat, P. ;

von Bergwet-Baidon, M. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (01) :21-31

[45] Addiction of primary cutaneous gamma-delta T-cell lymphoma to JAK-STAT signaling [J].

Zhang, Y. ;

Tefft, K. ;

Ng, S. ;

Qiu, K. ;

Yescas, J. ;

Wang, E. ;

Akhtar, S. ;

Walker, A. ;

Zaiac, M. ;

Qureshi, A. ;

Guitart, J. ;

Khodadoust, M. ;

Issa, N. T. ;

Choi, J. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) :S146-S146

[46] Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation [J].

Gopal, Ajay K. ;

Ramchandren, Radhakrishnan ;

O'Connor, Owen A. ;

Berryman, Robert B. ;

Advani, Ranjana H. ;

Chen, Robert ;

Smith, Scott E. ;

Cooper, Maureen ;

Rothe, Achim ;

Matous, Jeffrey V. ;

Grove, Laurie E. ;

Zain, Jasmine .

BLOOD, 2012, 120 (03) :560-568

[47] Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma - a systematic review [J].

Theurich, S. ;

Schlaak, M. ;

Pickenhain, J. ;

Skoetz, N. ;

Scheid, C. ;

Kurschat, P. ;

von Bergwelt-Baildon, M. .

ONKOLOGIE, 2012, 35 :6-6

[48] Brentuximab Vedotin in primary cutaneous CD30+large-cell anaplastic T-Cell Lymphoma [J].

Moritz, R. K. C. ;

Patsinakidis, N. ;

Terras, S. ;

Moellenhoff, K. ;

Gambichler, T. .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09) :921-921

[49] Allogeneic stem cell transplantation for patients with relapsed or chemorefractory T-cell lymphoma [J].

Wulf, G. G. ;

Hasenkamp, J. ;

Jung, W. ;

Wilhelm, C. ;

Held, G. ;

Nickelsen, M. ;

Pfreundschuh, M. ;

Schmitz, N. ;

Truemper, L. ;

Glass, B. .

ONKOLOGIE, 2011, 34 :24-24

[50] Brentuximab vedotin - a highly potent Therapy for cutaneous T-Cell Lymphoma [J].

Pax, A. T. ;

Stadler, R. .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 (12) :E6-E6

← 1 2 3 4 5 →